Teva USA Scholars Grants
A New Grant Program Administered by the
ACS Office of Research Grants
Award Information
Amount: $100,000 per year for 3 years
Number of awards: 3
Award period: September 1, 2009 to August 31, 2012
Eligibility
An applicant must be a recently-tenured faculty member of a PhD-granting department in the United States. Read more about for TEVA USA Scholars Grants.
Research Area and Evaluation Criteria
Applications for the TEVA USA Scholars grants must propose research in the area of organic chemistry, with potential or direct connections with medicinal chemistry, such that the successful results would be of practical benefit to the discovery of organic compounds useful as human medicines. Proposals are evaluated on: a) scientific merit, creativity and novelty; and b) addressing unexplored fields in organic and/or medicinal chemistry. General aspects of research proposals will also be considered, such as: Is the project achievable within the time frame? Are the personnel and facilities adequate? Does the applicant consider and address potential problems?
Budget Guidelines
The following budget restrictions apply:
No institutional overhead charges, nor facilities and administrative charges will be charged to the grant, nor will any be provided by ACS-TEVA.
Applications will include a budget in the amount of $100,000 for each of three years (Total = $300,000) with the following categories: personnel (multiple categories – below); reagents and expendables; permanent equipment; travel. A brief budget explanation should be part of the proposal; budget considerations may be part of the evaluation of the proposal.
A maximum of $10,000 per year may be used to support the principal investigator’s salary, including benefits. Postdoctoral fellows, research associates, technicians, graduate students (stipend and/or tuition), and/or undergraduate students may be supported through the grant, at levels commensurate with the grantee’s department or academic unit.
A maximum of $5,000 per year may be used for travel, including travel to conferences or symposia, or to collaborating laboratories. Travel to present research results must be budgeted for the third year; see below.
At the end of each grant year, the grantee will submit a financial report (and a scientific progress report; see below). Of the support given, funds remaining at the end of each grant year may be carried forward into the next.
Scientific and Financial Reporting Requirements
Each grant recipient is required to submit an annual scientific progress report as well as a financial report to the ACS Office of Research Grants for each year of the grant period. ACS shall, in its sole discretion and consistent with its standard practices, determine whether the grant recipient is meeting the goals and objectives appropriately.
Each grant recipient will be required to present a lecture during or promptly following the grant period at a time and place to be agreed upon by the grant recipient and the ACS. Recipients’ travel costs in connection with the lecture should be budgeted in travel for the third year. Preliminary plans are to arrange a symposium for the grantees at an ACS National Meeting.
2009 Teva USA Scholars Grants Recipients
Dr. Alexander Deiters, North Carolina State University, Small Molecules as New Probes and Therapeutics for Liver Diseases
Dr. Xin Guo, University of the Pacific, Trans-2-Aminocyclohexanol Lipids as pH-sensitive Conformational Switches in Liposomes for Drug Delivery
Dr. Brian Stoltz, California Institute of Technology, A Novel Approach to Antitumor Antibiotics
Program Manager
Dr. Jeffrey Smiley, telephone: (202) 872-6093, e-mail: j_smiley@acs.org